×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SION – sionna therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SION
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
07:00 am
sion
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
Low
Report
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
3/30
09:36 pm
sion
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story [Yahoo! Finance]
Medium
Report
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story [Yahoo! Finance]
3/18
12:01 pm
sion
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? [Yahoo! Finance]
Low
Report
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? [Yahoo! Finance]
3/16
04:01 pm
sion
Hot Picks: Biotech picks target cystic fibrosis trials and rare-disease drugs [BNN Bloomberg (Canada)]
Medium
Report
Hot Picks: Biotech picks target cystic fibrosis trials and rare-disease drugs [BNN Bloomberg (Canada)]
3/15
06:31 pm
sion
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares [Yahoo! Finance]
Low
Report
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares [Yahoo! Finance]
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
3/2
01:00 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
07:15 pm
sion
Form 4 Sionna Therapeutics, For: Apr 14 Filed by: Thompson Peter A.
Medium
Report
Form 4 Sionna Therapeutics, For: Apr 14 Filed by: Thompson Peter A.
4/16
07:04 pm
sion
Form 4 Sionna Therapeutics, For: Apr 14 Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form 4 Sionna Therapeutics, For: Apr 14 Filed by: ORBIMED ADVISORS LLC
3/6
06:56 pm
sion
Form 4 Sionna Therapeutics, For: Mar 05 Filed by: Fitzpatrick Jennifer
Medium
Report
Form 4 Sionna Therapeutics, For: Mar 05 Filed by: Fitzpatrick Jennifer
3/5
04:29 pm
sion
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
Medium
Report
Form 144 Sionna Therapeutics, Filed by: Fitzpatrick Jennifer
3/2
08:19 am
sion
Form S-3ASR Sionna Therapeutics,
Medium
Report
Form S-3ASR Sionna Therapeutics,
3/2
07:20 am
sion
Form 10-K Sionna Therapeutics, For: Dec 31
Medium
Report
Form 10-K Sionna Therapeutics, For: Dec 31
3/2
07:09 am
sion
Form 8-K Sionna Therapeutics, For: Mar 02
Medium
Report
Form 8-K Sionna Therapeutics, For: Mar 02
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: